These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 28739738)

  • 1. Cyclophilin A Is Overexpressed in Hepatocellular Carcinoma and Is Associated with the Cell Cycle.
    Gong Z; Chi C; Huang X; Chu H; Wang J; Du F; Jiang L; Chen J
    Anticancer Res; 2017 Aug; 37(8):4443-4447. PubMed ID: 28739738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9.
    Zhang M; Dai C; Zhu H; Chen S; Wu Y; Li Q; Zeng X; Wang W; Zuo J; Zhou M; Xia Z; Ji G; Saiyin H; Qin L; Yu L
    Mol Cell Biochem; 2011 Nov; 357(1-2):387-95. PubMed ID: 21667159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway.
    Li H; Miao Q; Xu CW; Huang JH; Zhou YF; Wu MJ
    J Korean Med Sci; 2016 Aug; 31(8):1215-23. PubMed ID: 27478331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination.
    Li T; Yan B; Ma Y; Weng J; Yang S; Zhao N; Wang X; Sun X
    Cell Death Dis; 2018 Feb; 9(2):148. PubMed ID: 29396555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas.
    Lee J
    Arch Pharm Res; 2010 Sep; 33(9):1401-9. PubMed ID: 20945139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophilin A Enhances Cell Proliferation and Xenografted Tumor Growth of Early Gastric Cancer.
    Feng W; Xin Y; Xiao Y; Li W; Sun D
    Dig Dis Sci; 2015 Sep; 60(9):2700-11. PubMed ID: 26008617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.
    Chen HW; Huang XD; Li HC; He S; Ni RZ; Chen CH; Peng C; Wu G; Wang GH; Wang YY; Zhao YH; Zhang YX; Shen AG; Wang HM
    Mol Carcinog; 2013 Aug; 52(8):647-59. PubMed ID: 22488567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.
    Li J; Gao JZ; Du JL; Huang ZX; Wei LX
    Int J Oncol; 2014 Oct; 45(4):1547-55. PubMed ID: 25069850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latexin exhibits tumor suppressor potential in hepatocellular carcinoma.
    Ni QF; Tian Y; Kong LL; Lu YT; Ding WZ; Kong LB
    Oncol Rep; 2014 Mar; 31(3):1364-72. PubMed ID: 24399246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-related receptor γ is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27.
    Kim JH; Choi YK; Byun JK; Kim MK; Kang YN; Kim SH; Lee S; Jang BK; Park KG
    Exp Mol Med; 2016 Mar; 48(3):e213. PubMed ID: 26940882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.
    Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y
    Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.
    Zhang SH; Qian YM; Liu AW; Cai J; Zhao XL; Wei JJ; Zhu MH
    Hum Pathol; 2012 Jul; 43(7):1084-93. PubMed ID: 22204716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q; Cai W; Zhang M; Liu Q; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27.
    Wang D; Han S; Peng R; Jiao C; Wang X; Yang X; Yang R; Li X
    J Exp Clin Cancer Res; 2016 Feb; 35():37. PubMed ID: 26911146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147 stimulates hepatoma cells escaping from immune surveillance of T cells by interaction with Cyclophilin A.
    Ren YX; Wang SJ; Fan JH; Sun SJ; Li X; Padhiar AA; Zhang JN
    Biomed Pharmacother; 2016 May; 80():289-297. PubMed ID: 27133068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6.
    Du S; Lu L; Miao Y; Jin W; Li C; Xin Y; Xuan S
    Lipids Health Dis; 2017 Apr; 16(1):76. PubMed ID: 28407767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival.
    Lu G; Shan T; He S; Ren M; Zhu M; Hu Y; Lu X; Zhang D
    Oncol Rep; 2013 Nov; 30(5):2238-44. PubMed ID: 23970101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
    Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.